New Kit Lets Vaccine Manufacturers Test 5′ Capping Efficiency at the Bench, With Answers in Less Than Two Hours

Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields

Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers.

SingleTimeMicroneedles to showcase STM Patch in the Food, Nutrition, and Health category

The noted Atlanta, Georgia urgent care, along with providing the new COVID-19 vaccine, offers need-to-know knowledge about the booster that targets Omicron subvariants, BA.4 and BA.5.

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.

Utilizing proprietary nano-coating technology, Forge Nano is able to fundamentally improve nearly any material on earth at the atomic level.

The updated document presents five reasons why the vaccination status of other schoolchildren is not a significant risk to immunocompromised schoolchildren

OcyonBio CDMO welcomes cell and gene therapy expert Robert Salcedo who brings over 20 years of expertise in the areas of CMC, operations, and supply chain management and has served in multi-billion-dollar companies operating in biotech, vaccines, and pharmaceutical markets.

Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.

Gen-Z-led non-profit Up To Us and polling partner INTRVL share detailed, county-level data on unvaccinated adults, who have a wide range of motivations for not getting the COVID-19 vaccine. There are 25 million people across the country who could be persuaded to get the shot. They are more concerned about adverse health effects in comparison to vaccine-resistant adults, who are more conspiratorial.

Go maskless, when allowed, without people thinking you are unvaccinated.

The last-mile vaccination effort in the Bay Area

Major cancer biological therapy market players include AbbVie, Merck, AstraZeneca, GlaxoSmithKline, ELI Lilly and Company, Otsuka, Pfizer, Hoffmann-La Roche, Novartis and Takeda Pharmaceuticals.

The doctors say it's time to debunk years of myths and distrust

Single-use bioreactors market is estimated to attain a CAGR of 20.2% through 2027 owing to various advantages such as reduced cross contamination, cost-effectiveness, flexibility and increased productivity.

New release also eliminates vaccine waste and enhances patient safety

Top Priority is to Serve and Support Customers, Employees & Communities

Vaccine App & Website Streamlining Vaccinations for the Healthcare Industry

Vaccine App & Website to Support Communities Through COVID-19 & Flu Season

Report addresses the need for a firebreak to stop the spread of disease and the increasing hesitancy of people getting vaccinated

Two Mothers Take on Medical Tyranny: Invite Top Scientists, Doctors, Journalists, and Scholars for a Quarantine-Compliant Online Summit.

The Germany bioreactors market contributed to over 25% of regional revenue share in 2018 and projected to achieve lucrative growth in coming years supported by the presence of leading industry players and increasing healthcare expenditure in this region.

The Office of Public Health is holding a special, no cost to the patient vaccination day on Thursday, Dec. 13, 2018, from 2 p.m. to 6:30 p.m., and CARE, Inc., encourages all employees, clients, and their families to take advantage.

Relationship Seeks to Re-Establish Rochester as Pediatric Research Leader

According to a new market research report launched by Inkwood Research, the Global DNA vaccines Market is growing at a CAGR of 41.89% during the forecast period 2018-2026.

MMJ Labs CEO Publishes New Study Related to Needle Pain

Grant Funding Will Support Preclinical Development of Two Vaccines Using Vaxess's MIMIX™ Delivery Platform

Filmmaker Joins Robert Kennedy Jr. and Robert De Niro on Stage at National Press Club for a Groundbreaking Press Conference

This pipeline analysis focuses on Immune Checkpoint therapeutics.

Veterinary vaccines play a vital role improving the health of animals and boosting their immune system, thereby keeping them away from various infections and diseases. Increased adoption rate of pets has surged the demand for their vaccines in order to keep them healthy and disease-free. The market for veterinary vaccines has undergone a complete transformation from what it was in the past few years.

The report provides a comprehensive analysis of market size of global and Latin America animal health care industry, market segmentation of Latin America animal health care industry by pharmaceuticals, vaccines and medical feeds.

Global Research & Data Services is going to publish several market analyses about the markets for vaccines around the world.

Pro Pharma Pharmaceutical Consultants, Inc., a pharmaceutical consultant organization which focuses on data analytical expertise, announced today that it has introduced new-improved enhancements to the JCode Calculator™ for claims and billing exper

CSO Harriet L. Robinson Honored as Distinguished Emeritus Faculty;
Chairman David A. Dodd To Receive Alumni Award from Georgia State University

FastMed Urgent Care provides individual adult and children's flu vaccinations for $15 at all of their North Carolina locations

Dr. Jon Heinrichs, Director, Microbial Vaccines, Merck Research Laboratories, to deliver featured speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference (Nov. 7-8, 2011, in Boston, MA).

Erik Henchal, Associate Director, Management and Scientific Affairs, Office of Vaccine Research and Review Food and Drug Administration, to deliver featured speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference.

Non Human Primate Study Demonstrates Unprecedented 70% Prevention of Infection

New scientific findings and statistical data disclose that vaccines not only fail to prevent the diseases they are supposed to protect us from, but they actually cause or contribute to them.

Today, Global Research & Data Services is going to publish several market analyses about the markets for vaccines in different European countries.

GeoVax has decided to expand its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials

The article, titled "Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles," will appear in the March 1 issue of The Journal of Infectious Diseases.

Biomedical Treatment for Autism is a new website that shares video interviews of parents, researchers and medical professionals talking about alternative medical interventions that reverse the symptoms of Autism.

The grant was awarded following GeoVax's submission for consideration of its HIV/AIDS vaccine research and development project to the U.S. Secretary of Health and Human Services.

Because of the difficulty raising antibodies that are capable of totally blocking natural HIV infections, the GeoVax vaccine approach has focused on raising cellular immune responses in addition to antibodies.

GeoVax is developing a vaccine that presents the natural form of HIV envelope proteins to the immune system on virus-like particles with the envelope proteins present in clusters of three, a confirmation known as trimers.

Since 1995, National HIV Testing Day has united organizations across the nation every June 27th to promote the early diagnosis of HIV.

Although the GeoVax vaccines are currently being studied for HIV prevention, this is the first study using the same products for treatment of persons who already have HIV infection. ARCA is the only site for this trial.

NewsRx has published a new encyclopedia on vaccines -- Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals.